A simplified summary of CBDv (Cannabidivarin)
For the full and scientific summary, scroll down.
CBDv is part of the “Varin” cannabinoid family and is closely related to CBD. Even though the compound was first discovered in 1969 by Dr Vollner, research on the therapeutic benefits of this cannabinoid is in its early stages.
Medicinal benefits of CBDv
Although the research surrounding CBDv is relatively new, scientists have shown promising results that point to the fact that CBDv may help treat or relieve the symptoms in regards to the following medical conditions:
– CBDv may have potential as an anti-seizure medication for epilepsy by modulating the activity of the TRPV1-receptor.
– CBDv also seems to modulate the activity of glutamate, a neurotransmitter that is also linked with several other neurological disorders (including epilepsy).
– CBDv seems to be of particular interest in the research of rare diseases like Fragile-X-Syndrome (1) and Rett Syndrome (3)
– Further studies are being done on the benefits that CBDv brings to pain-, inflammatory disease, and obesity management.
– There are also promising signs that CBDv may support or stimulate the growth of stem cells (MSCs) in our bone marrow.
CBDv and the entourage effect
According to early research, it seems that CBDv’s beneficial effects on epilepsy are multiplied by combining it with the terpene Linalool. And for the stimulation of stem cell growth, a combination of CBDv and THCv seems to be more effective.